-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Tyra Biosciences, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2020 to Q2 2024.
- Tyra Biosciences, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $4.83M, a 76.1% increase year-over-year.
- Tyra Biosciences, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $14.6M, a 72.3% increase year-over-year.
- Tyra Biosciences, Inc. annual Nonoperating Income (Expense) for 2023 was $10.8M, a 200% increase from 2022.
- Tyra Biosciences, Inc. annual Nonoperating Income (Expense) for 2022 was $3.6M.
- Tyra Biosciences, Inc. annual Nonoperating Income (Expense) for 2021 was -$6K, a 84.6% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)